Showing results (561-570 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|February 7, 2022
Estimands in observational studies: Some considerations beyond ICH E9 (R1)Heng Li, Chenguang Wang, Wei-Chen Chen, et al.Pharmaceutical Statistics|May 20, 2022
Empirical likelihood inference for area under the receiver operating characteristic curve using ranked set samplesChul Moon, Xinlei Wang, Johan LimPharmaceutical Statistics|June 28, 2022
Estimators for handling COVID-19-related intercurrent events with a hypothetical strategyFlorian Lasch, Lorenzo GuizzaroPharmaceutical Statistics|November 4, 2006
Operational challenges in adaptive design implementationPaul GalloPharmaceutical Statistics|July 12, 2026
The Impact of Model Misspecification on the Individual Causal Association in Surrogate Endpoint EvaluationGokce Deliorman, Florian Stijven, Wim Van der Elst, et al.Pharmaceutical Statistics|August 10, 2026
A Fast, Flexible Simulation Framework for Bayesian Adaptive Designs-The R Package BATSSDominique-Laurent Couturier, Rainer Puhr, Stephane Heritier, et al.Pharmaceutical Statistics|August 21, 2026
Seamless Phase I-II Cancer Clinical Trials Using Kernel-Based Covariate SimilarityKana Makino, Natsumi Makigusa, Masahiro KojimaPharmaceutical Statistics|August 14, 2026
Dose Optimization Design for Randomized Phase II Trials With Toxicity and Efficacy EndpointsRyuta Tabata, Tomohiro Ohigashi, Takashi SozuPharmaceutical Statistics|September 13, 2026
Use of Composite Priors for Assurance of Sequential Therapy Trials: Practical Experiences Using Binary Endpoint DataJonathan Wright, Li YePharmaceutical Statistics|September 29, 2026
A Practical Guide to Optimal Adaptive Two-Stage Designs for Various Endpoint TypesNico Bruder, Jan Meis, Maximilian Pilz, et al.Pageof 119